AnnouncementsCipla appoints Peter Mugyenyi as additional director
AnnouncementsCipla: Q3 results on Feb 12, 2014
|Company Name||Last Price||%
|Dr Reddys Labs||2676.50||-0.47||2939.80||1786.50||45,529.64|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
Cipla is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 30,246.05 crore.The company has reported a consolidated sales of Rs 2,552.63 crore and a Net Profit of Rs 296.53 crore for the quarter ended Dec 2013.
The company management includes Y K Hamied - Executive Vice Chairman, Subhanu Saxena - Managing Director & Global CEO, M K Hamied - Managing Director, S Radhakrishnan - Whole Time Director, H R Manchanda - Non Executive Director, V C Kotwal - Non Executive Director, M R Raghavan - Non Executive Director, Pankaj Patel - Non Executive Director, Ramesh Shroff - Non Executive Director, Ashok Sinha - Additional Director, Peter Mugyenyi - Independent Director.
It is listed on the BSE with a BSE Code of 500087 and the NSE with an NSE Code of CIPLA.
Its Registered office is at Mumbai Central , Mumbai,Maharashtra - 400008.
Their Registrars are Karvy Computershare Private Ltd.